Lipase Levels and Coronavirus Disease 2019

Uşak University

Status: Completed

Conditions: Pancreatitis; Lipase Increased

Treatments: Other: Age, gender, hospitalization and mortality rates will be compared

Study type: Observational

Funder types: Other

Identifiers

NCT05601258

UsakUCevdet3

Details and patient eligibility

About

Although COVID-19 disease due to Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the respiratory tract, heart and coagulation system, symptoms of gastrointestinal system involvement such as abdominal pain, nausea, vomiting and diarrhea are also common.

In this study, it was aimed retrospective analysis of clinical and laboratory data of patients who developed pancreatic injury and acute pancreatitis in the course of COVID 19 disease.

Enrollment: 4,000 patients

Sex

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with lipase levels measured during COVID-19

Exclusion criteria

Patients with age <18 years Patients with pregnancy Patients whose lipase levels were not measured in the course of COVID-19 Patients with known solid organ malignacy Patients with known hematologic malignacy

Trial design

4,000 participants in 2 patient groups

patients with higher lipase level

Description:

patients with higher lipase levels (higher than the laboratory upper limits) in the course of SARS-CoV-2 infection

Treatment:

Other: Age, gender, hospitalization and mortality rates will be compared

Control

Description:

patients with normal lipase levels in the course of SARS-CoV-2 infection

Treatment:

Other: Age, gender, hospitalization and mortality rates will be compared